Esther Hian Li Chan

5PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 21, 2026
A Phase I/II Trial of Anti-CD22/CD19 CAR-T Cell Therapy, CART2219.1, in Adult and Pediatric Relapsed/Refractory B-ALL.

|Jul 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's Lymphoma.

Rui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib

|Apr 18, 2023
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma.

Michal Marek Hoppe, Patrick Jaynes, Fan Shuangyi

|Jun 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells.

Wen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung

|Jul 03, 2019
Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.

Esther Hian Li Chan, Liang Piu Koh, Joanne Lee

Pageof 1

Frequent Collaborators

3 joint publications

Michelle L M Poon

2 joint publications

Soo-Yong Tan

2 joint publications

Anand D Jeyasekharan

2 joint publications

Soon Thye Lim